References

  Pleasance et al., 2010, A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010 Jan 14; 463(7278):191-6.

  Mardis ER, 2010, The $1,000 genome, the $100,000 analysis? Genome Med. 2010 Nov 26; 2(11):84.

  Wang Z, Gerstein M, Snyder M., 2009, RNA-Seq: a revolutionary tool for transcriptomics.Nat Rev Genet. 2009 Jan; 10(1):57-63.

  Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ., 2005, An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res. 2005 May 15; 65(10):4031-40.

  Esteller M., 2008, Epigenetics in cancer.N Engl J Med. 2008 Mar 13; 358(11):1148-59.

  Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga J, Bruin S, Kerr D, Kuppen P, van de Velde C, Morreau H, Van Velthuysen L, Glas AM, Van't Veer LJ, Tollenaar R., 2011, Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.J Clin Oncol. 2011 Jan 1; 29(1):17-24.

  Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR., 2009, Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009 Nov 19; 462(7271):315-22.

  Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R., 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma.N Engl J Med. 2005 Mar 10; 352(10):997-1003.

  Stephanie Conklin, Bing Yang, Nate Baird, Brad Baas, Ali Crawford, Melissa Won, Nancy Kim, Damian Goodridge, Alex Lindell, Gerald P. Morris, 2015, Improved HLA typing by next-generation DNA sequencing, Human Immunology, Volume 76, Supplement, October 2015, Page 63, ISSN 0198-8859.

  S. Beck, J. Trowsdale, 1999, Sequence organisation of the class II region of the human MHC Immunol. Rev., 167 (1999), pp. 201–210.

  Shiina T.G., Takishima N., Inoko, H., 1999, Genome sequencing analysis of the 1.8 Mb human MHC class I region Immunol. Rev., 167 (1999), pp. 193–199

  Marsh S.G.E., Nomenclature for factors of the HLA system: update March 2000, Tissue Antigens, 56 (2000), pp. 103–104

Quick Enquiry